[EN] COMPOUNDS AND PROCESSES FOR THE PREPARATION OF ERIBULIN [FR] COMPOSÉS ET PROCÉDÉS POUR LA PRÉPARATION D'ÉRIBULINE
摘要:
The present invention relates to compounds and a process for the preparation of eribulin. More specifically, the process to prepare the C14- C35 sulfone fragment of eribulin (i.e. compounds of formula I) by reacting a C14-C26 ketone fragment of eribulin (i.e. compounds of formula II) with a C27-C35 sulfonium salt fragment (i.e. compounds of formula III) under Corey-Chaykovsky reaction conditions is explored. The processes to prepare the intermediate C14-C26 ketone (i.e. compounds of formula II), the intermediate C27-C35 sulfonium salt (i.e. compounds of formula III) and the intermediate C27-C35 aldehyde (i.e. compounds of formula IV) arc also disclosed.
[EN] COMPOUNDS AND PROCESSES FOR THE PREPARATION OF ERIBULIN [FR] COMPOSÉS ET PROCÉDÉS POUR LA PRÉPARATION D'ÉRIBULINE
摘要:
The present invention relates to compounds and a process for the preparation of eribulin. More specifically, the process to prepare the C14- C35 sulfone fragment of eribulin (i.e. compounds of formula I) by reacting a C14-C26 ketone fragment of eribulin (i.e. compounds of formula II) with a C27-C35 sulfonium salt fragment (i.e. compounds of formula III) under Corey-Chaykovsky reaction conditions is explored. The processes to prepare the intermediate C14-C26 ketone (i.e. compounds of formula II), the intermediate C27-C35 sulfonium salt (i.e. compounds of formula III) and the intermediate C27-C35 aldehyde (i.e. compounds of formula IV) arc also disclosed.
Second Generation Synthesis of C27−C35 Building Block of E7389, a Synthetic Halichondrin Analogue
作者:Yu-Rong Yang、Dae-Shik Kim、Yoshito Kishi
DOI:10.1021/ol9016589
日期:2009.10.15
A practical method is reported to synthesize E7389 C27−C35 building block 13 from 1,2-O-isopropylidene-α-d-5-deoxyglucurono-6,3-lactone (3). This synthesis relies on two key processes: (1) C34/C35-diol is introduced via asymmetric dihydroxylation with dr = 3:1, with the undesired C34-diastereomer effectively removed by crystallization of 11, and (2) the C30 PhSO2CH2 group is introduced stereoselectively